Detalhe da pesquisa
1.
Efficient production of immunologically active Shigella invasion plasmid antigens IpaB and IpaH using a cell-free expression system.
Appl Microbiol Biotechnol
; 106(1): 401-414, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34932164
2.
Development of an Aotus nancymaae model for Shigella Vaccine immunogenicity and efficacy studies.
Infect Immun
; 82(5): 2027-36, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24595138
3.
Shigella virulence protein VirG is a broadly protective antigen and vaccine candidate.
NPJ Vaccines
; 9(1): 2, 2024 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38167387
4.
Development of the Shigella flexneri 2a, 3a, 6, and S. sonnei artificial Invaplex (InvaplexAR) vaccines.
mSphere
; 8(4): e0007323, 2023 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37389412
5.
A Novel Shigella O-Polysaccharide-IpaB Conjugate Vaccine Elicits Robust Antibody Responses and Confers Protection against Multiple Shigella Serotypes.
mSphere
; 8(3): e0001923, 2023 Jun 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37017547
6.
GMP manufacture of Shigella flexneri 2a Artificial Invaplex (InvaplexAR) and evaluation in a Phase 1 Open-label, dose escalating study administered intranasally to healthy, adult volunteers.
Vaccine
; 41(42): 6261-6271, 2023 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37666695
7.
From Concept to Clinical Product: A Brief History of the Novel Shigella Invaplex Vaccine's Refinement and Evolution.
Vaccines (Basel)
; 10(4)2022 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35455297
8.
Enteric disease surveillance under the AFHSC-GEIS: current efforts, landscape analysis and vision forward.
BMC Public Health
; 11 Suppl 2: S7, 2011 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-21388567
9.
Invaplex functions as an intranasal adjuvant for subunit and DNA vaccines co-delivered in the nasal cavity of nonhuman primates.
Vaccine X
; 8: 100105, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34258576
10.
Genetics and virulence association of the Shigella flexneri sit iron transport system.
Infect Immun
; 77(5): 1992-9, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19289511
11.
Assembly, Biochemical Characterization, Immunogenicity, Adjuvanticity, and Efficacy of Shigella Artificial Invaplex.
mSphere
; 3(2)2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29600284
12.
Improving chances for successful clinical outcomes with better preclinical models.
Vaccine
; 35(49 Pt A): 6798-6802, 2017 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-28890194
13.
Multiplexed immunoassay to assess Shigella-specific antibody responses.
J Immunol Methods
; 393(1-2): 18-29, 2013 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-23583496
14.
Surveillance for enteric pathogens in a case-control study of acute diarrhea in Western Kenya.
Trans R Soc Trop Med Hyg
; 107(2): 83-90, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23222955
15.
Safety and immunogenicity of an intranasal Shigella flexneri 2a Invaplex 50 vaccine.
Vaccine
; 29(40): 7009-19, 2011 Sep 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-21787825
16.
Inactivated and subunit vaccines to prevent shigellosis.
Expert Rev Vaccines
; 8(12): 1693-704, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19943764
17.
Mucosal adjuvanticity of a Shigella invasin complex with dna-based vaccines.
Clin Vaccine Immunol
; 16(4): 574-86, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19225079
18.
Immunogenicity and efficacy of highly purified invasin complex vaccine from Shigella flexneri 2a.
Vaccine
; 26(10): 1353-64, 2008 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-18276045
19.
Enteric pathogen surveillance in a case-control study of acute diarrhoea in the town of Kisii, Kenya.
J Med Microbiol
; 62(Pt 11): 1774-1776, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23842139
20.
Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine.
Vaccine
; 24(13): 2290-301, 2006 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-16364513